FUMIYA YONEYAMA to Receptors, Androgen
This is a "connection" page, showing publications FUMIYA YONEYAMA has written about Receptors, Androgen.
Connection Strength
0.234
-
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study. Int J Clin Oncol. 2025 Sep; 30(9):1858-1865.
Score: 0.187
-
Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer. Int J Clin Oncol. 2025 Dec; 30(12):2635-2642.
Score: 0.047